The Ledger

5 days: that is how long University of Miami Health System and UnitedHealthcare have left to reach a new network contract before hundreds of thousands of patients go out of network. University of Miami Health System (UHealth) says on its own negotiation page that a new contract must be in place by July 31, 2026, or the system exits UnitedHealthcare’s network starting August 1 for commercial, exchange and Medicaid plans, with a later, separate September 1, 2026 deadline for UnitedHealthcare’s Medicare Advantage Preferred Care Network members; both institutions’ pages were last updated July 21 to July 22, 2026 and show no resolution since. UHealth, anchored by the Bascom Palmer Eye Institute, says UnitedHealthcare’s reimbursement lags what the insurer pays comparable South Florida systems, while UnitedHealthcare says UHealth is “seeking significant price hikes that would increase health care costs for families and employers.” Confidence: High on the deadline and the absence of a deal, since both parties’ own pages confirm it directly. Low on how it resolves, since neither side has signaled movement publicly. Sources: UHealth and UnitedHealthcare Negotiation, University of Miami Health System, Network Negotiations with Miami Health System (UHealth), UnitedHealthcare.

1.07 billion dollars: that is the combined federal Medicaid funding the Trump administration is withholding from two states this month, citing suspected fraud in claims the states say are being unfairly targeted. The Department of Health and Human Services said July 21, 2026 that it is deferring approximately 867.5 million dollars in federal Medicaid matching funds to California, tied largely to the state’s in-home care programs, and about 199 million dollars to Minnesota, spanning 14 categories of claims the agency calls high risk, pending review of suspected fraud and noncompliance; HHS Secretary Robert F. Kennedy Jr. announced the deferrals at a press conference. Both states dispute the fraud characterization and are weighing legal challenges, according to trade press; the deferrals withhold cash both states’ Medicaid managed care organizations and providers otherwise expect on their normal payment schedule, though they are not permanent cuts. Confidence: High on the dollar figures and the deferral itself, since HHS’s own release confirms them directly. Low on whether the money is ultimately released or clawed back, since the review is still underway. Sources: HHS Defers More Than $1 Billion in Medicaid Payments to California, Minnesota Pending Review of High-Risk Claims in Crackdown on Fraud, U.S. Department of Health and Human Services, Trump administration pauses $1B in Medicaid payments to California, Minnesota, Healthcare Dive.

1.9 billion dollars: that is the equity value of Tempus AI’s deal to buy a smaller cancer-testing rival, structured so Tempus can pay up to half in cash if it chooses. Personalis, Inc. announced July 20, 2026 that it agreed to be acquired by Tempus AI, Inc. for 16.25 dollars per share, valuing Personalis’ equity at approximately 1.9 billion dollars in a deal structured as 100 percent stock, with Tempus holding the option to pay up to 50 percent of the consideration in cash instead. Tempus said the deal deepens its position in molecular residual disease testing, tests that check for cancer recurrence after treatment, a market the company estimates at 20 billion dollars, by combining Personalis’ technology with Tempus’ commercial scale and multimodal patient data; the transaction is expected to close in late 2026 or early 2027 pending shareholder and regulatory approval. Confidence: High on the deal terms, since they come directly from Tempus AI’s own investor relations release. Medium on the market-size figure, since it is the company’s own estimate rather than an independent analysis. Source: Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform, Tempus AI investor relations.

7: that is how many acquisitions a private-equity-backed staffing platform has made in 24 months, chasing a quarter billion dollars in annual revenue by the end of this year. Care Career announced July 24, 2026 that it acquired MAS Medical Staffing, its seventh acquisition in 24 months, pushing the combined company’s annualized revenue above 150 million dollars with a stated goal of exceeding 250 million dollars by the end of 2026; terms were not disclosed. The deal is the latest in a wave of private-equity-backed consolidation in healthcare staffing, alongside Knox Lane’s 437 million dollar all-cash acquisition of Cross Country Healthcare, which completed July 21, 2026, as buyers bet on scale to win hospital and health-system staffing contracts as travel-nurse demand normalizes. Confidence: High on the Care Career figures, since they come from the company’s own release. Medium on how the broader staffing roll-up wave affects pricing for hospital buyers, since that effect has not been independently studied. Sources: Care Career Announces Acquisition of MAS Medical Staffing, PR Newswire, Knox Lane Completes Acquisition of Cross Country Healthcare, BusinessWire.

FRONTIER SCAN. 4: that is how many malpractice verdicts a single regional health system has taken in 2026 alone, the latest a 17 million dollar award this week over a wrong-organ removal, as national malpractice premiums post a seventh straight year of increases. A Kennebec County, Maine jury awarded 17 million dollars on July 24, 2026, 15.75 million dollars to a patient and 1.25 million dollars to her husband, after finding Northern Light Health and Inland Hospital negligent when a surgeon removed her bladder instead of an ovarian cyst in 2023; it is the fourth malpractice verdict against Northern Light Health in 2026, with awards this year ranging from 750,000 dollars to 23.1 million dollars, and the largest malpractice verdict in the county’s history. It follows an 18.2 million dollar verdict a Wake County, North Carolina jury returned July 14, 2026 against WakeMed Raleigh Campus and a resident physician in a birth-injury case, and lands amid a broader trend: the American Medical Association’s own economists found in an April 2026 report that 39.9 percent of reported medical liability premiums rose in 2025, the seventh consecutive year of increases, with at least 11 states posting rate increases of 10 percent or more. Insurers are responding by consolidating; The Doctors Company closed its 1.3 billion dollar all-cash acquisition of ProAssurance Corporation in late June 2026, creating a physician-owned liability insurer with about 12 billion dollars in assets, second in scale only to Berkshire Hathaway’s MedPro Group, as AM Best has tracked a multiyear run of industrywide underwriting losses in the segment. Confidence: High on the individual verdict figures and the AMA and AM Best data, since they come from court reporting and the organizations’ own publications. Medium on how directly the verdict trend is driving the consolidation, since carriers cite multiple pressures. This scan adds Medical Liability Monitor (medicalliabilitymonitor.com), an independent trade publication whose annual rate survey and Milliman-compiled quarterly carrier-financials analysis underlie most of this reporting, to our source stack. Sources: Grant & Eisenhofer Wins Record $18.2M Jury Verdict in Birth Injuries Case, Lawdragon, Northern Light Health, Inland Hospital ordered to pay jury award in bladder removal lawsuit, Bangor Daily News, For the seventh consecutive year, medical liability premiums continue to rise, American Medical Association, The Doctors Company Completes Acquisition of ProAssurance Corporation, PR Newswire.

THE DEAL SHEET

Target	Acquirer/Investor	Vertical	Value	Source
Personalis, Inc.	Tempus AI, Inc.	Precision oncology, molecular residual disease testing	$16.25/share, approximately $1.9 billion equity value, up to 50% payable in cash	Tempus AI investor relations
MAS Medical Staffing	Care Career	Healthcare staffing	Undisclosed	Care Career Announces Acquisition of MAS Medical Staffing, PR Newswire
Cross Country Healthcare, Inc.	Knox Lane	Healthcare workforce solutions	$437 million all-cash (closing completed July 21)	Knox Lane Completes Acquisition of Cross Country Healthcare, BusinessWire
Valera Health and Janus Healthcare Partners	Mindoula Health (backed by Equality Asset Management)	Behavioral health, collaborative care	Undisclosed	Mindoula Expands Whole Person Care Enablement Platform Through Strategic Acquisitions, PRWeb
AdventHealth’s 5 Denver-area hospitals and Intermountain Health’s 3 Colorado hospitals	Joint venture, letter of intent, AdventHealth to manage	Hospital system consolidation	Not disclosed; expected to close early 2027	AdventHealth, Intermountain Health Plan Partnership to Strengthen Healthcare for Denver Metro Communities, Intermountain Health newsroom

No payer earnings or 8-Ks dropped over the weekend. Universal Health Services reports Monday, July 27, followed by Centene around July 28, Boston Scientific and Teladoc Health July 29, Humana also July 29, Privia Health, agilon health, Oscar Health and Clover Health cluster in early August, and Cigna July 30.